With the rapid development and complex challenges of chemical substances, new drug synthesis pathways are usually the most effective.100125-12-0,3,8-Dibromo-1,10-phenanthroline,as a common compound, the synthetic route is as follows.
General procedure: Activated Mg turnings (0.71 g, 29.21 mmol) in anhydrous thf (5 mL) and a catalytic amount of iodine were added to a flame-dried 100 mL three-necked flask and stirred vigorously at room temperature under argon. Then a solution of 2-bromo-5- methylthiophene (1.7 mL, 15.10 mmol) in anhydrous thf (5 mL) was slowly added dropwise to the reaction mixture. Once the vigorous reaction had started, the rest of the 2-bromo-5-methylthiophene solution was added dropwise to keep the mixture at reflux. The mixture was then heated at reflux for 30 min and added through a cannula into an ice-cooled solution of 3,8-dibromo-1,10- phenanthroline (2.01 g, 5.95 mmol) and [Ni(dppp)Cl2] (0.09 g, 0.17 mmol) in dry thf (50 mL). After stirring at room temperature for 2 h, the reaction mixture was heated at reflux for another 12 h, cooled to room temperature, quenched with saturated NH4Cl aqueous solution, and extracted thoroughly with chloroform (CHCl3) until no more products could be detected by TLC. The organic layer was washed with brine and purified by column chromatography (silica gel; CHCl3/petroleum ether, 1:1).
100125-12-0, The synthetic route of 100125-12-0 has been constantly updated, and we look forward to future research findings.
Reference£º
Article; Zhang, Bo; Cao, Kou-Sen; Xu, Ze-An; Yang, Zhe-Qin; Chen, Hao-Wen; Huang, Wei; Yin, Gui; You, Xiao-Zeng; European Journal of Inorganic Chemistry; 24; (2012); p. 3844 – 3851;,
Metal catalyst and ligand design
Ligand Template Strategies for Catalyst Encapsulation – NCBI